Alzchem Group Ag Stock Fundamentals
| ACT Stock | EUR 57.00 1.20 2.06% |
AlzChem Group AG fundamentals help investors to digest information that contributes to AlzChem Group's financial success or failures. It also enables traders to predict the movement of AlzChem Stock. The fundamental analysis module provides a way to measure AlzChem Group's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to AlzChem Group stock.
AlzChem |
AlzChem Group AG Company EBITDA Analysis
AlzChem Group's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current AlzChem Group EBITDA | 62.69 M |
Most of AlzChem Group's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, AlzChem Group AG is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
According to the company disclosure, AlzChem Group AG reported earnings before interest,tax, depreciation and amortization of 62.69 M. This is much higher than that of the sector and significantly higher than that of the EBITDA industry. The ebitda for all Germany stocks is notably lower than that of the firm.
AlzChem Group AG Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining AlzChem Group's current stock value. Our valuation model uses many indicators to compare AlzChem Group value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across AlzChem Group competition to find correlations between indicators driving AlzChem Group's intrinsic value. More Info.AlzChem Group AG is rated below average in current valuation category among its peers. It also is rated below average in price to book category among its peers . The ratio of Current Valuation to Price To Book for AlzChem Group AG is about 200,200,603 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the AlzChem Group's earnings, one of the primary drivers of an investment's value.AlzChem EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses AlzChem Group's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of AlzChem Group could also be used in its relative valuation, which is a method of valuing AlzChem Group by comparing valuation metrics of similar companies.AlzChem Group is currently under evaluation in ebitda category among its peers.
AlzChem Fundamentals
| Current Valuation | 256.64 M | |||
| Price To Book | 1.28 X | |||
| Price To Sales | 0.35 X | |||
| Revenue | 422.29 M | |||
| EBITDA | 62.69 M | |||
| Net Income | 27.59 M | |||
| Total Debt | 37.55 M | |||
| Cash Flow From Operations | 43.02 M | |||
| Total Asset | 377.67 M | |||
| Z Score | 1.0 | |||
| Net Asset | 377.67 M |
About AlzChem Group Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze AlzChem Group AG's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AlzChem Group using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AlzChem Group AG based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in AlzChem Stock
AlzChem Group financial ratios help investors to determine whether AlzChem Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in AlzChem with respect to the benefits of owning AlzChem Group security.